EPIVX Fees and Costs — EuroPac International Value Fund, Class A
Data updated: 2026-09-28
The net expense ratio is 1.71%. This share class carries a maximum front-end sales load of 4.50%. In fiscal 2025 the fund paid $43K in broker commissions, 0.0290% of average net assets, and portfolio turnover was 31%.
EPIVX Fees and Expenses
Annual operating expenses and sales charges of EPIVX. Prospectus, as of October 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 1.08% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.36% |
| Gross expense ratio | 1.71% |
| Fee waiver | — |
| Net expense ratio | 1.71% |
| Sales charges | |
|---|---|
| Max front load | 4.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
EPIVX Costs Over Time
On $10,000 invested in EPIVX, assuming 5% a year before costs, total costs come to $1,598 over 5 years, cutting the return by 2.77% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $450 | $450 | $450 |
| Fund expenses (net expense ratio 1.71%) | $171 | $531 | $914 |
| Trading costs (broker commissions) | $3 | $9 | $15 |
| Lost growth on money paid in costs | $23 | $98 | $219 |
| Total costs | $647 | $1,088 | $1,598 |
| Value after costs | $9,853 | $10,489 | $11,165 |
| Impact on return, per year | 6.47% | 3.40% | 2.77% |
EPIVX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0290%
- Total broker commissions: $43K
- Bought from dealers (principal trades, not a cost): $60.7M
- Portfolio turnover (prospectus): 31%
- Securities lending: none during the year
EPIVX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| INSTINET, LLC | $29K | 87.06% |
| RAYMOND JAMES (USA) LTD. | $4K | 12.94% |
EPIVX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BROWN BROTHERS HARRIMAN & CO. | $60.7M | 99.87% |
| BNP PARIBAS SECURITIES CORP. | $58K | 0.10% |
| Beacon Securities Limited | $24K | 0.04% |
EuroPac International Value Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| EPVIX | Class I | 1.46% | none |
| EPIVX | Class A | 1.71% | 4.50% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.